7.3 C
New York
Thursday, April 25, 2024
HomeMarkets
Markets

Tesaro Volatile After Johnson & Johnson Suspends Enrollment In Prostate Cancer Trial

By Insider Scoop
0
35
psw-placeholder
psw-placeholder

Courtesy of Benzinga.

TESARO Inc (NASDAQ: TSRO) shares are trading higher by $0.33 at $140.00 in Friday’s session.

The stock fell out of bed around 10:00 a.m. ET, when Johnson & Johnson (NYSE: JNJ) suspended enrollment of Tesaro’s Niraparib Phase 2 prostrate cancer trial pending review of data collected.

In a matter of 16 minutes, Tesaro’s stock swooned from the $139.00 area all the way to $125.05 before staging a dramatic rebound. The stock was struggling to recover until 11:00 a.m. when Wells Fargo came out and defended the issue.

At this time, the rebound off the low took Tesaro’s stock within a few pennies of the session high ($140.74) but retreated to the $140.00 area.

Posted-In: Technicals Intraday Update Movers Trading Ideas

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,324FansLike
396,312FollowersFollow
2,290SubscribersSubscribe

Latest Articles

Load more

Note: The material presented in this commentary is provided for informational purposes only and is based upon information that is considered to be reliable. However, neither PSW Investments, LLC d/b/a PhilStockWorld (PSW) nor its affiliates warrant its completeness, accuracy or adequacy and it should not be relied upon as such. Neither PSW nor its affiliates are responsible for any errors or omissions or for results obtained from the use of this information. Past performance, including the tracking of virtual trades and portfolios for educational purposes, is not necessarily indicative of future results. Neither Phil, Optrader, or anyone related to PSW is a registered financial adviser and they may hold positions in the stocks mentioned, which may change at any time without notice. Do not buy or sell based on anything that is written here, the risk of loss in trading is great.

This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only intended at the moment of their issue as conditions quickly change. The information contained herein does not constitute advice on the tax consequences of making any particular investment decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation to you of any particular securities, financial instruments or strategies. Before investing, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

Contact us: support@philstockworld.com

© Copyright - PSW, LLC.

2024
0
Would love your thoughts, please comment.x
()
x